Applications of 4-Imidazoleacetic Acid Hydrochloride in Industrial Manufacturing

4-Imidazoleacetic Acid Hydrochloride serves specialized functions across pharmaceutical synthesis, biochemical research reagents, enzyme assay formulation, and neurochemical standards. As a direct manufacturer, we supply this intermediate with controlled quality to maintain consistency and safety in demanding downstream processes.

1. Pharmaceutical API Intermediate for Histamine Derivatives

Pharmaceutical producers commonly incorporate 4-Imidazoleacetic Acid Hydrochloride as a core intermediate to synthesize histaminergic drug compounds. Its imidazole backbone enables precise functionalization under mild conditions, supporting multi-step synthesis for antihistamines and CNS-targeted pharmaceuticals. Process engineers oversee controlled addition timing to maximize purity outputs, meeting regulatory batch records and traceability mandates from raw material introduction through final tablet or injectable formulation.

Industry compliance standards

• ICH Q7 GMP Guidelines for Active Pharmaceutical Ingredients
• EU GMP Annex 8 (Sampling of Starting and Packaging Materials)
• USP-NF, Ph. Eur. reference for purity, residual solvents, and elemental impurities
• FDA 21 CFR Part 211 (Finished Pharmaceuticals GMP)

Typical usage ratio

• Raw material load ranges from 0.08 to 0.24 molar equivalents per batch, scaled based on the targeted synthesis route and API throughput

Downstream process integration

• Batch-wise feed in the initial or intermediate alkylation step of the multi-stage histamine derivatization synthesis
• Filtration and extraction before subsequent purification by crystallization or chromatography

Final product types

• Antihistamine oral and injectable dosage forms
• Central nervous system modulators containing functionalized imidazole moieties

2. Research-Grade Biochemical Reagents Production

Many life sciences reagent manufacturers select this hydrochloride salt for stable imidazole-acetic acid preparation used in analytical kit buffers and enzyme substrate solutions. Batch traceability from incoming raw material to reagent bottle helps labs comply with audit requirements for research integrity and reproducibility. Technical teams measure the addition precisely to ensure pH and chelation reactivity within validated kit recipes, essential for downstream diagnostic workflows and research screening.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for production traceability
• ISO 13485:2016 for medical and diagnostic reagents with quality documentation
• REACH Registration for chemical safety data
• Certificate of Analysis (CoA) lot control as per company SOP

Typical usage ratio

• 0.5%–2.0% w/v in buffer preparations for assay kit components, with final concentration adjusted according to buffer ionic strength requirements and chelation profile

Downstream process integration

• Dissolution in aqueous matrix during buffer compounding under filtered, climate-controlled conditions
• pH monitored during blending to guarantee lot-to-lot consistency for end-users

Final product types

• Enzyme-linked immunosorbent assay (ELISA) kits
• Enzyme activity detection buffers
• Cell culture and research analytical reagent solutions

3. Enzyme Activity Assay Calibration and Standardization

Certified analytical labs and specialty enzymology kit manufacturers rely on accurate standardization of histaminergic enzyme activity using 4-Imidazoleacetic Acid Hydrochloride as a calibration substance. Technicians blend the raw material into working and reference standards to support kinetic measurements and validation protocols. Batch homogeneity and designation of storage conditions uphold assay validity for regulatory and accreditation obligations.

Industry compliance standards

• ISO/IEC 17025:2017 for laboratory calibration and testing competencies
• CLSI EP05-A3 (Evaluation of Precision) for clinical assay kit manufacturing
• Internal QC lot specification and reference traceability to NIST/EU standards where applicable
• Material Safety Data Sheet (MSDS) management under GHS

Typical usage ratio

• 50–200 μM in enzyme calibration standard preparations, depending on dynamic range and detection limit of the assay

Downstream process integration

• Measured addition to standard curves or QC mixtures during final reagent blending stage
• Precise aliquoting, blending, and stability validation before filling kits

Final product types

• Enzymatic assay control standards for accredited pathology laboratories
• Diagnostic calibration sets for clinical instrumentation

4. Reference Substance for Neurochemical Analytical Standards

Reference material producers specify 4-Imidazoleacetic Acid Hydrochloride as a neurochemical marker when formulating certified standards for HPLC, GC-MS, or LC-MS analysis of brain tissue and biological fluids. Analysts require tight lot consistency to ensure linearity in quantitative studies. Preparation involves controlled dilution and lyophilization steps, compatible with trace-level detection and method validation protocols. Compliance with reference material handling ensures deliverability for forensics, clinical diagnostics, and pharmaceutical research sectors.

Industry compliance standards

• ISO 17034:2016 for reference material producers
• ISO Guide 33 (Characterization and Assessment of Reference Materials for Chemical Analysis)
• IUPAC Gold Book criteria for chemical reference standard purity
• Storage and transport regulations under IATA/ADR for laboratory reference substances

Typical usage ratio

• Prepared as 10–100 μg/mL solutions or lyophilized powder, with final concentration adjusted by end-use instrument calibration curves

Downstream process integration

• Dissolved and homogenized during standard solution or set batchmaking
• Subdivided into ampoules or vials under nitrogen to prevent degradation before distribution to labs

Final product types

• Chemical reference standards for CNS biomarker analysis
• Quality control materials for forensic and clinical neurochemistry labs
• Instrument calibration standards for pharmaceutical assay validations